Table 3.

Plasma GST-α concentration before and after 4 wks of daily Polyphenon E administration

GST-α concentration (ng/mL)*
P
BaselinePosttreatment
All participants (N = 42)7.46 ± 6.547.59 ± 6.910.770
Baseline level in the lowest tertile (n = 14)3.32 ± 0.545.17 ± 4.190.136
Baseline level in the middle tertile (n = 14)5.52 ± 0.665.09 ± 1.650.334
Baseline level in the highest tertile (n = 14)13.5 ± 8.4712.5 ± 9.530.003
  • * Mean ± 1 SD.